Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients

Carswell, C
Win, Z
Muckle, K
Kennedy, A
Waldman, A
Dawe, G
Barwick, T
Khan, S
Malhotra, PA
Perry, R

September 2017

Background and objective Amyloid-positron emission tomography (PET) imaging (API) detects amyloid-be...

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u27s disease dementia, mild cognitive impairment, and normal aging

Johnson, Keith A.
Sperling, Reisa A.
Gidicsin, Christopher M.
Carmasin, Jeremy S.
Maye, Jacqueline E.
Coleman, Ralph E.
Reiman, Eric M.
Sabbagh, Marwan N.
Sadowsky, Carl H.
Fleisher, Adam S.
Murali Doraiswamy, P.
Carpenter, Alan P.
Clark, Christopher M.
Joshi, Abhinay D.
Lu, Ming
Grundman, Michel
Mintun, Mark A.
Pontecorvo, Michel J.
Skovronsky, Daniel M.

October 2013

Objective: To evaluate the performance characteristics of florbetapir F18 positron emission tomograp...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [18F]-florbetapir (INDIA-FBP) study

Boccardi M.
Altomare D.
Ferrari C.
Festari C.
Guerra U. P.
Paghera B.
Pizzocaro C.
Lussignoli G.
Geroldi C.
Zanetti O.
Cotelli M. S.
Turla M.
Borroni B.
Rozzini L.
Mirabile D.
Defanti C.
Gennuso M.
Prelle A.
Gentile S.
Morandi A.
Vollaro S.
Volta G. D.
Bianchetti A.
Conti M. Z.
Cappuccio M.
Carbone P.
Bellandi D.
Abruzzi L.
Bettoni L.
Villani D.
Raimondi M. C.
Lanari A.
Ciccone A.
Facchi E.
Di Fazio I.
Rozzini R.
Boffelli S.
Manzoni L.
Salvi G. P.
Cavaliere S.
Belotti G.
Avanzi S.
Pasqualetti P.
Muscio C.
Padovani A.
Frisoni G. B.
Antelmi L.
Galluzzi S.
Pievani M.
Redolfi A.
Tarallo A.
Arora A.
Bertocchi M.
Chito E.
Moretti D. V.
Giubbini R.
Rodella C.
Camoni L.
Massetti V.
Andreoli M.
Bellelli G.
Fascendini S.
Mattioli F.
Turco R.
Vezzadini G.
Raimondi V.
Mondini S.
Zanacchi E. C.
Grigolo M.
Pezzini A.
Bilotti G.
Bigni B.
Zavarise P.
Ngonga G.
Anzola G. P.
Turrone R.
Guizzetti G.
Zanetti M.

January 2016

IMPORTANCE Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected i...

18F-Florbetapir and 18F-FDG PET studies in the diagnostic evaluation of Alzheimer's disease

Gragnaniello, Daniela
Cittanti, Corrado
Rambaldi, Ilaria
Milani, Paola
Santi, Ivan
Tugnoli, Valeria

January 2016

Clinical diagnosis of AD remains a challenge since there are no validated tests for an affirmative d...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [ 18 F]-florbetapir (INDIA-FBP) study

Boccardi, Marina
Altomare, Daniele
Ferrari, Clarissa
Festari, Cristina
Guerra, Ugo Paolo
Paghera, Barbara
Pizzocaro, Claudio
Lussignoli, Giulia
Geroldi, Cristina
Zanetti, Orazio
Cotelli, Maria Sofia
Turla, Marinella
Borroni, Barbara
Rozzini, Luca
Mirabile, Dario
Defanti, Carlo
Gennuso, Michele
Prelle, Alessandro
Gentile, Simona
Morandi, Alessandro
VOLLARO, STEFANO
Volta, Giorgio Dalla
Bianchetti, Angelo
Conti, Marta Zaffira
Cappuccio, Melania
CARBONE, PASQUALINA
Bellandi, Daniele
Abruzzi, Luciano
Bettoni, Luigi
Villani, Daniele
Raimondi, Maria Clara
Lanari, Alessia
Ciccone, Alfonso
Facchi, Emanuela
Di Fazio, Ignazio
Rozzini, Renzo
Boffelli, Stefano
Manzoni, Laura
Salvi, Giovanni Pietro
Cavaliere, Sabina
BELOTTI, GLORIA
Avanzi, Stefano
Pasqualetti, Patrizio
Muscio, Cristina
Padovani, Alessandro
Frisoni, Giovanni B.
Antelmi, Luigi
Galluzzi, Samantha
Pievani, Michela
Redolfi, Alberto
TARALLO, ANNA ROSA
Arora, Anupa
Bertocchi, Monica
Chitò, Eugenia
Moretti, Davide V.
Giubbini, Raffaele
Rodella, Carlo
Camoni, Luca
Massetti, Valentina
Andreoli, Michela
Bellelli, Giuseppe
Fascendini, Sara
Mattioli, Flavia
Turco, Renato
Vezzadini, Giuliana
Raimondi, Vanessa
Mondini, Sara
Zanacchi, Elisa Carolina
Grigolo, Marta
Pezzini, Alessandra
Bilotti, Giacinta
Bigni, Barbara
Zavarise, Paola
Ngonga, Gael
Anzola, Gian Paolo
Turrone, Rosanna
Guizzetti, Gianluca
Zanetti, Marina

January 2016

Importance Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected ...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [ 18 F]-florbetapir (INDIA-FBP) study

Boccardi, Marina
Altomare, Daniele
Ferrari, Clarissa
Festari, Cristina
Guerra, Ugo Paolo
Paghera, Barbara
Pizzocaro, Claudio
Lussignoli, Giulia
Geroldi, Cristina
Zanetti, Orazio
Cotelli, Maria Sofia
Turla, Marinella
Borroni, Barbara
Rozzini, Luca
Mirabile, Dario
Defanti, Carlo
Gennuso, Michele
Prelle, Alessandro
Gentile, Simona
Morandi, Alessandro
VOLLARO, STEFANO
Volta, Giorgio Dalla
Bianchetti, Angelo
Conti, Marta Zaffira
Cappuccio, Melania
CARBONE, PASQUALINA
Bellandi, Daniele
Abruzzi, Luciano
Bettoni, Luigi
Villani, Daniele
Raimondi, Maria Clara
Lanari, Alessia
Ciccone, Alfonso
Facchi, Emanuela
Di Fazio, Ignazio
Rozzini, Renzo
Boffelli, Stefano
Manzoni, Laura
Salvi, Giovanni Pietro
Cavaliere, Sabina
BELOTTI, GLORIA
Avanzi, Stefano
Pasqualetti, Patrizio
Muscio, Cristina
Padovani, Alessandro
Frisoni, Giovanni B.
Antelmi, Luigi
Galluzzi, Samantha
Pievani, Michela
Redolfi, Alberto
TARALLO, ANNA ROSA
Arora, Anupa
Bertocchi, Monica
Chitò, Eugenia
Moretti, Davide V.
Giubbini, Raffaele
Rodella, Carlo
Camoni, Luca
Massetti, Valentina
Andreoli, Michela
Bellelli, Giuseppe
Fascendini, Sara
Mattioli, Flavia
Turco, Renato
Vezzadini, Giuliana
Raimondi, Vanessa
Mondini, Sara
Zanacchi, Elisa Carolina
Grigolo, Marta
Pezzini, Alessandra
Bilotti, Giacinta
Bigni, Barbara
Zavarise, Paola
Ngonga, Gael
Anzola, Gian Paolo
Turrone, Rosanna
Guizzetti, Gianluca
Zanetti, Marina

January 2016

Importance Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected ...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [18F]-florbetapir (INDIA-FBP) study

Boccardi M.
Altomare D.
Ferrari C.
Festari C.
Guerra U. P.
Paghera B.
Pizzocaro C.
Lussignoli G.
Geroldi C.
Zanetti O.
Cotelli M. S.
Turla M.
Borroni B.
Rozzini L.
Mirabile D.
Defanti C.
Gennuso M.
Prelle A.
Gentile S.
Morandi A.
Vollaro S.
Volta G. D.
Bianchetti A.
Conti M. Z.
Cappuccio M.
Carbone P.
Bellandi D.
Abruzzi L.
Bettoni L.
Villani D.
Raimondi M. C.
Lanari A.
Ciccone A.
Facchi E.
Di Fazio I.
Rozzini R.
Boffelli S.
Manzoni L.
Salvi G. P.
Cavaliere S.
Belotti G.
Avanzi S.
Pasqualetti P.
Muscio C.
Padovani A.
Frisoni G. B.
Antelmi L.
Galluzzi S.
Pievani M.
Redolfi A.
Tarallo A.
Arora A.
Bertocchi M.
Chito E.
Moretti D. V.
Giubbini R.
Rodella C.
Camoni L.
Massetti V.
Andreoli M.
Bellelli G.
Fascendini S.
Mattioli F.
Turco R.
Vezzadini G.
Raimondi V.
Mondini S.
Zanacchi E. C.
Grigolo M.
Pezzini A.
Bilotti G.
Bigni B.
Zavarise P.
Ngonga G.
Anzola G. P.
Turrone R.
Guizzetti G.
Zanetti M.

January 2016

IMPORTANCE Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected i...

The use of amyloid imaging in clinical praxis: a critical review

Nordberg, Agneta

February 2015

Recent development in molecular imaging enables measurement of fibrillar amyloid plaque in Alzheimer...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
De La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
GUILLOTEAU, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients

Carswell, C
Win, Z
Muckle, K
Kennedy, A
Waldman, A
Dawe, G
Barwick, T
Khan, S
Malhotra, PA
Perry, R

September 2017

Background and objective Amyloid-positron emission tomography (PET) imaging (API) detects amyloid-be...

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u27s disease dementia, mild cognitive impairment, and normal aging

Johnson, Keith A.
Sperling, Reisa A.
Gidicsin, Christopher M.
Carmasin, Jeremy S.
Maye, Jacqueline E.
Coleman, Ralph E.
Reiman, Eric M.
Sabbagh, Marwan N.
Sadowsky, Carl H.
Fleisher, Adam S.
Murali Doraiswamy, P.
Carpenter, Alan P.
Clark, Christopher M.
Joshi, Abhinay D.
Lu, Ming
Grundman, Michel
Mintun, Mark A.
Pontecorvo, Michel J.
Skovronsky, Daniel M.

October 2013

Objective: To evaluate the performance characteristics of florbetapir F18 positron emission tomograp...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [18F]-florbetapir (INDIA-FBP) study

Boccardi M.
Altomare D.
Ferrari C.
Festari C.
Guerra U. P.
Paghera B.
Pizzocaro C.
Lussignoli G.
Geroldi C.
Zanetti O.
Cotelli M. S.
Turla M.
Borroni B.
Rozzini L.
Mirabile D.
Defanti C.
Gennuso M.
Prelle A.
Gentile S.
Morandi A.
Vollaro S.
Volta G. D.
Bianchetti A.
Conti M. Z.
Cappuccio M.
Carbone P.
Bellandi D.
Abruzzi L.
Bettoni L.
Villani D.
Raimondi M. C.
Lanari A.
Ciccone A.
Facchi E.
Di Fazio I.
Rozzini R.
Boffelli S.
Manzoni L.
Salvi G. P.
Cavaliere S.
Belotti G.
Avanzi S.
Pasqualetti P.
Muscio C.
Padovani A.
Frisoni G. B.
Antelmi L.
Galluzzi S.
Pievani M.
Redolfi A.
Tarallo A.
Arora A.
Bertocchi M.
Chito E.
Moretti D. V.
Giubbini R.
Rodella C.
Camoni L.
Massetti V.
Andreoli M.
Bellelli G.
Fascendini S.
Mattioli F.
Turco R.
Vezzadini G.
Raimondi V.
Mondini S.
Zanacchi E. C.
Grigolo M.
Pezzini A.
Bilotti G.
Bigni B.
Zavarise P.
Ngonga G.
Anzola G. P.
Turrone R.
Guizzetti G.
Zanetti M.

January 2016

IMPORTANCE Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected i...

18F-Florbetapir and 18F-FDG PET studies in the diagnostic evaluation of Alzheimer's disease

Gragnaniello, Daniela
Cittanti, Corrado
Rambaldi, Ilaria
Milani, Paola
Santi, Ivan
Tugnoli, Valeria

January 2016

Clinical diagnosis of AD remains a challenge since there are no validated tests for an affirmative d...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [ 18 F]-florbetapir (INDIA-FBP) study

Boccardi, Marina
Altomare, Daniele
Ferrari, Clarissa
Festari, Cristina
Guerra, Ugo Paolo
Paghera, Barbara
Pizzocaro, Claudio
Lussignoli, Giulia
Geroldi, Cristina
Zanetti, Orazio
Cotelli, Maria Sofia
Turla, Marinella
Borroni, Barbara
Rozzini, Luca
Mirabile, Dario
Defanti, Carlo
Gennuso, Michele
Prelle, Alessandro
Gentile, Simona
Morandi, Alessandro
VOLLARO, STEFANO
Volta, Giorgio Dalla
Bianchetti, Angelo
Conti, Marta Zaffira
Cappuccio, Melania
CARBONE, PASQUALINA
Bellandi, Daniele
Abruzzi, Luciano
Bettoni, Luigi
Villani, Daniele
Raimondi, Maria Clara
Lanari, Alessia
Ciccone, Alfonso
Facchi, Emanuela
Di Fazio, Ignazio
Rozzini, Renzo
Boffelli, Stefano
Manzoni, Laura
Salvi, Giovanni Pietro
Cavaliere, Sabina
BELOTTI, GLORIA
Avanzi, Stefano
Pasqualetti, Patrizio
Muscio, Cristina
Padovani, Alessandro
Frisoni, Giovanni B.
Antelmi, Luigi
Galluzzi, Samantha
Pievani, Michela
Redolfi, Alberto
TARALLO, ANNA ROSA
Arora, Anupa
Bertocchi, Monica
Chitò, Eugenia
Moretti, Davide V.
Giubbini, Raffaele
Rodella, Carlo
Camoni, Luca
Massetti, Valentina
Andreoli, Michela
Bellelli, Giuseppe
Fascendini, Sara
Mattioli, Flavia
Turco, Renato
Vezzadini, Giuliana
Raimondi, Vanessa
Mondini, Sara
Zanacchi, Elisa Carolina
Grigolo, Marta
Pezzini, Alessandra
Bilotti, Giacinta
Bigni, Barbara
Zavarise, Paola
Ngonga, Gael
Anzola, Gian Paolo
Turrone, Rosanna
Guizzetti, Gianluca
Zanetti, Marina

January 2016

Importance Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected ...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [ 18 F]-florbetapir (INDIA-FBP) study

Boccardi, Marina
Altomare, Daniele
Ferrari, Clarissa
Festari, Cristina
Guerra, Ugo Paolo
Paghera, Barbara
Pizzocaro, Claudio
Lussignoli, Giulia
Geroldi, Cristina
Zanetti, Orazio
Cotelli, Maria Sofia
Turla, Marinella
Borroni, Barbara
Rozzini, Luca
Mirabile, Dario
Defanti, Carlo
Gennuso, Michele
Prelle, Alessandro
Gentile, Simona
Morandi, Alessandro
VOLLARO, STEFANO
Volta, Giorgio Dalla
Bianchetti, Angelo
Conti, Marta Zaffira
Cappuccio, Melania
CARBONE, PASQUALINA
Bellandi, Daniele
Abruzzi, Luciano
Bettoni, Luigi
Villani, Daniele
Raimondi, Maria Clara
Lanari, Alessia
Ciccone, Alfonso
Facchi, Emanuela
Di Fazio, Ignazio
Rozzini, Renzo
Boffelli, Stefano
Manzoni, Laura
Salvi, Giovanni Pietro
Cavaliere, Sabina
BELOTTI, GLORIA
Avanzi, Stefano
Pasqualetti, Patrizio
Muscio, Cristina
Padovani, Alessandro
Frisoni, Giovanni B.
Antelmi, Luigi
Galluzzi, Samantha
Pievani, Michela
Redolfi, Alberto
TARALLO, ANNA ROSA
Arora, Anupa
Bertocchi, Monica
Chitò, Eugenia
Moretti, Davide V.
Giubbini, Raffaele
Rodella, Carlo
Camoni, Luca
Massetti, Valentina
Andreoli, Michela
Bellelli, Giuseppe
Fascendini, Sara
Mattioli, Flavia
Turco, Renato
Vezzadini, Giuliana
Raimondi, Vanessa
Mondini, Sara
Zanacchi, Elisa Carolina
Grigolo, Marta
Pezzini, Alessandra
Bilotti, Giacinta
Bigni, Barbara
Zavarise, Paola
Ngonga, Gael
Anzola, Gian Paolo
Turrone, Rosanna
Guizzetti, Gianluca
Zanetti, Marina

January 2016

Importance Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected ...

Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment: The incremental diagnostic value of amyloid PET with [18F]-florbetapir (INDIA-FBP) study

Boccardi M.
Altomare D.
Ferrari C.
Festari C.
Guerra U. P.
Paghera B.
Pizzocaro C.
Lussignoli G.
Geroldi C.
Zanetti O.
Cotelli M. S.
Turla M.
Borroni B.
Rozzini L.
Mirabile D.
Defanti C.
Gennuso M.
Prelle A.
Gentile S.
Morandi A.
Vollaro S.
Volta G. D.
Bianchetti A.
Conti M. Z.
Cappuccio M.
Carbone P.
Bellandi D.
Abruzzi L.
Bettoni L.
Villani D.
Raimondi M. C.
Lanari A.
Ciccone A.
Facchi E.
Di Fazio I.
Rozzini R.
Boffelli S.
Manzoni L.
Salvi G. P.
Cavaliere S.
Belotti G.
Avanzi S.
Pasqualetti P.
Muscio C.
Padovani A.
Frisoni G. B.
Antelmi L.
Galluzzi S.
Pievani M.
Redolfi A.
Tarallo A.
Arora A.
Bertocchi M.
Chito E.
Moretti D. V.
Giubbini R.
Rodella C.
Camoni L.
Massetti V.
Andreoli M.
Bellelli G.
Fascendini S.
Mattioli F.
Turco R.
Vezzadini G.
Raimondi V.
Mondini S.
Zanacchi E. C.
Grigolo M.
Pezzini A.
Bilotti G.
Bigni B.
Zavarise P.
Ngonga G.
Anzola G. P.
Turrone R.
Guizzetti G.
Zanetti M.

January 2016

IMPORTANCE Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected i...

The use of amyloid imaging in clinical praxis: a critical review

Nordberg, Agneta

February 2015

Recent development in molecular imaging enables measurement of fibrillar amyloid plaque in Alzheimer...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
De La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
GUILLOTEAU, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus, Vincent
Payoux, Pierre
Barré, Louisa
Desgranges, Béatrice
Voisin, Thierry
Tauber, Clovis
La Joie, Renaud
Tafani, Mathieu
Hommet, Caroline
Chételat, Gaël
Mondon, Karl
de La Sayette, Vincent
Cottier, Jean-Philippe
Beaufils, Emilie
Ribeiro, Maria-Joao
Gissot, Valérie
Vierron, Emilie
Vercouillie, Johnny
Skovronsky, D.
Vellas, Bruno
Eustache, Francis
Guilloteau, Denis

April 2012

International audiencePURPOSE: Positron emission tomography (PET) imaging of brain amyloid load has ...

Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients

Carswell, C
Win, Z
Muckle, K
Kennedy, A
Waldman, A
Dawe, G
Barwick, T
Khan, S
Malhotra, PA
Perry, R

September 2017

Background and objective Amyloid-positron emission tomography (PET) imaging (API) detects amyloid-be...

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u27s disease dementia, mild cognitive impairment, and normal aging

Johnson, Keith A.
Sperling, Reisa A.
Gidicsin, Christopher M.
Carmasin, Jeremy S.
Maye, Jacqueline E.
Coleman, Ralph E.
Reiman, Eric M.
Sabbagh, Marwan N.
Sadowsky, Carl H.
Fleisher, Adam S.
Murali Doraiswamy, P.
Carpenter, Alan P.
Clark, Christopher M.
Joshi, Abhinay D.
Lu, Ming
Grundman, Michel
Mintun, Mark A.
Pontecorvo, Michel J.
Skovronsky, Daniel M.

October 2013

Objective: To evaluate the performance characteristics of florbetapir F18 positron emission tomograp...

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Abstract

Extracted data

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Abstract

Extracted data

Related items

Related items